Dr. Kathryn Martin Remington is a Technical Consultant in the Global Scientific and Regulatory Consultancy group, Contract Testing Services, MilliporeSigma. Kathy joined the organization in 2010 and has supported clients in developing appropriate viral safety testing programs for their products. Prior to joining MilliporeSigma, she was at Catalent Pharma Solutions for seven years where she established and managed their viral clearance program. She was also the Section Head of the Viral Validation group for Bayer Healthcare. During her over 25 years in viral clearance, she has authored a number of publications on the viral safety of biopharmaceuticals. Kathy earned her M.S. and Ph.D. degrees in Microbiology from the University of Montana.
